Large Cap Biotech
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Trend Stats
1-Month Return
-3.19%
3-Month Return
-3.14%
12-Month Return
+39.54%
Volatility Score
2.0
RSI
48.9
ST Trend
Down
LT Trend
Up
Short-Term Trend
Down
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Large Cap Biotech
S&P 500 Index
Components
| Symbol | Company | Market Cap | 12 mo return Performance over the past 12 months | 3 mo return Performance over the past 3 months | 1 mo return Performance over the past month | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| AMGN | Amgen | $183B | +28.65% | -8.78% | -1.17% | 2.3 | Down | Up |
| GILD | Gilead Sciences | $167B | +28.46% | -10.75% | +1.10% | 2.4 | Down | Up |
| VRTX | Vertex Pharma | $110B | -0.34% | -8.89% | -0.72% | 2.4 | Down | Down |
| REGN | Regeneron Pharma | $67B | +9.19% | -17.94% | -14.30% | 3.7 | Down | Down |
| ARGX | arGEN-X SpADR | $50B | +37.24% | -4.49% | +1.67% | 3.0 | Up | Neutral |
| ALNY | Alnylam Pharma | $40B | +2.58% | -11.52% | -4.23% | 3.7 | Down | Down |
| RVMD | REVOLUTION MEDIC | $32B | +281.09% | +48.84% | +7.11% | 4.4 | Up | Up |
| ONC | BeOne Medi Sp ADR | $32B | +28.51% | -14.33% | -0.69% | 2.8 | Up | Down |
| NTRA | Natera | $29B | +32.53% | -4.21% | -2.21% | 5.2 | Neutral | Neutral |
| BIIB | Biogen | $29B | +54.01% | +0.90% | +1.94% | 3.1 | Up | Up |
| UTHR | United Therapeut | $24B | +84.77% | +20.07% | -1.02% | 2.6 | Neutral | Up |
| BNTX | BioNTech Sp ADR | $23B | -6.63% | -16.35% | -15.16% | 3.6 | Down | Down |
| INSM | Insmed | $23B | +57.32% | -35.58% | -26.47% | 7.2 | Down | Down |
| ILMN | Illumina | $22B | +79.68% | +22.72% | +10.66% | 3.9 | Up | Up |
| ROIV | ROIVANT SCIENCES | $22B | +175.62% | +10.35% | +2.78% | 3.8 | Up | Up |
| INCY | Incyte | $19B | +51.23% | -4.11% | +0.43% | 3.1 | Neutral | Neutral |
| MRNA | MODERNA | $19B | +78.52% | -6.00% | -15.68% | 7.0 | Down | Up |
| GMAB | GENMAB SP ADR | $16B | +29.12% | -8.26% | -2.96% | 3.0 | Down | Down |
| NBIX | Neurocrine Biosc | $16B | +30.39% | +21.82% | +19.45% | 2.9 | Up | Up |
| ASND | Ascendis Sp ADR | $15B | +52.50% | +9.80% | +6.92% | 3.8 | Up | Up |
| BBIO | BRIDGEBIO PHARMA | $14B | +107.32% | +1.44% | -7.15% | 5.5 | Down | Up |
| SMMT | SUMMIT THERAP | $13B | -35.71% | +4.27% | -32.38% | 8.3 | Down | Down |
| EXEL | Exelixis | $13B | +18.31% | +14.94% | +7.04% | 3.2 | Up | Up |
| IONS | Ionis Pharmaceut | $12B | +129.11% | -9.13% | +0.98% | 3.3 | Neutral | Up |
| MEDP | Medpace Holdings | $12B | +46.77% | -4.62% | -14.88% | 3.1 | Down | Down |
| AXSM | Axsome Therapeut | $12B | +124.58% | +28.44% | +26.58% | 4.2 | Up | Up |
| MDGL | Madrigal Pharmct | $12B | +93.32% | +18.91% | -2.25% | 4.2 | Neutral | Up |
| ARWR | Arrowhead Phrmct | $11B | +395.37% | +17.86% | +1.39% | 5.1 | Up | Up |
| BMRN | Biomarin Pharm | $10B | -6.01% | -15.59% | -0.11% | 3.4 | Down | Down |
| CYTK | Cytokinetics | $10B | +151.93% | +13.25% | +16.14% | 4.9 | Up | Up |
| ABVX | ABIVAX SP ADS | $9.7B | +2051.50% | -6.41% | +5.17% | 4.5 | Up | Up |
| PRAX | PRAXIS PRECIS | $9.6B | +814.94% | +2.47% | +1.86% | 6.0 | Up | Up |
| KRYS | KRYSTAL BIOTECH | $8.8B | +139.46% | +14.38% | +8.52% | 4.3 | Up | Up |
| TEM | TEMPUS AI-A | $8.3B | -26.18% | -20.88% | -16.81% | 6.0 | Down | Down |
| HALO | Halozyme Therape | $8.1B | +25.27% | -3.75% | -0.12% | 3.6 | Up | Down |
| NUVL | NUVALENT-A | $8.1B | +38.96% | +1.61% | -6.18% | 3.7 | Down | Up |
| CRL | Charles Riv Lab | $7.7B | +17.24% | -5.10% | -13.26% | 5.0 | Down | Down |
| IBRX | IMMUNITYBIO | $7.6B | +185.38% | -17.01% | -10.53% | 8.2 | Down | Up |
| TECH | Bio-Techne | $7.5B | +3.68% | -16.03% | -17.55% | 5.9 | Down | Down |
| IMVT | IMMUNOVANT | $7B | +136.17% | +28.38% | +15.80% | 5.6 | Up | Up |
| 0 | 0 | 0 | 0 | Bullish | Bullish |